Lazari Capital Management, Inc. Humacyte, Inc. Transaction History
Lazari Capital Management, Inc.
- $266 Billion
- Q2 2025
A detailed history of Lazari Capital Management, Inc. transactions in Humacyte, Inc. stock. As of the latest transaction made, Lazari Capital Management, Inc. holds 13,044 shares of HUMA stock, worth $31,566. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,044Holding current value
$31,566% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
186Shares Held
60MCall Options Held
1.05MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$17.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$16 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$10.3 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$9.74 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$9.56 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $249M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...